[1]
|
C. P. J. Blower, J. S. Lewis and J. Zweit, “Copper Radionuclides and Radiopharmaceuticals in Nuclear Medicine,” Nuclear Medicine and Biology, Vol. 23, No. 8, 1996, pp. 957-980. doi:10.1016/S0969-8051(96)00130-8
|
[2]
|
T. J. Wadas, E. H. Wong, G. R. Weisman and C. J. Anderson, “Copper Chelation Chemistry and Its Role in Copper Radiopharmaceuticals,” Current Pharmaceutical Design, Vol. 13, No. 1, 2007, pp. 3-16.
doi:10.2174/138161207779313768
|
[3]
|
A. Obata, S. Kasamatsu, J. S. Lewis, T. Furukawa, S. Takamatsu, J. Toyohara, T. Asai, M. J. Welch, S. G. Adams, H. Saji, Y. Yonekura and Y. Fujibayashi, “Basic Characterization of 64Cu-ATSM as a Radiotherapy Agent,” Nuclear Medicine and Biology, Vol. 32, No. 1, 2005, pp. 21-28. doi:10.1016/j.nucmedbio.2004.08.012
|
[4]
|
A. Obata, M. Yoshimoto, S. Kasamatsu, H. Naiki, S. Takamatsu, K. Kashikura, T. Furukawa, J. S. Lewis, M. J. Welch, H. Saji, Y. Yonekura and Y. Fujibayashi, “Intra-Tumoral Distribution of 64Cu-ATSM: A Comparison Study with FDG,” Nuclear Medicine and Biology, Vol. 30, No. 5, 2003, pp. 529-534.
doi:10.1016/S0969-8051(03)00047-7
|
[5]
|
P. McQuade, K. E. Martin, T. C. Castle, M. J. Went, P. J. Blower, M. J. Welch and J. S. Lewis, “Investigation into 64Cu-labeled Bis(selenosemicarbazone) and Bis(thiosemicarbazone) Complexes as Hypoxia Imaging Agents,” Nuclear Medicine and Biology, Vol. 32, No. 2, 2005, pp. 147-156. doi:10.1016/j.nucmedbio.2004.10.004
|
[6]
|
A. Obata, S. Kasamatsu, D. W. McCarthy, M. J. Welch, H. Saji, Y. Yonekura and Y. Fujibayashi, “Production of Therapeutic Quantities of 64Cu Using a 12 MeV Cyclotron,” Nuclear Medicine and Biology, Vol. 30, No. 5, 2003, pp. 535-539. doi:10.1016/S0969-8051(03)00024-6
|
[7]
|
M. A. Avila-Rodriguez, J. A. Nyeb and R. J. Nickles, “Simultaneous Production of High Specific Activity 64Cu and 61Co with 11.4 MeV Protons on Enriched 64Ni Nuclei,” Applied Radiation and Isotopes, Vol. 65, No. 10, 2007, pp. 1115-1120. doi:10.1016/j.apradiso.2007.05.012
|
[8]
|
X. Hou, U. Jacobsen and J. C. Jorgensen, “Separation of No-Carrier-Added 64Cu from a Proton Irradiated 64Ni Enriched Nickel Target,” Applied Radiation and Isotopes, Vol. 57, No. 6, 2002, pp. 773-777.
doi:10.1016/S0969-8043(02)00170-7
|
[9]
|
D. W. McCarthy, R. E. Shefer, R. E. Klinkowstein, L. A. Bass, W. H. Margeneau, C. S. Culter, C. J. Anderson and M. J. Welch, “Efficient Production of High Specific Activity 64Cu Using a Biomedical Cyclotron,” Nuclear Medicine and Biology, Vol. 24, No. 1, 1997, pp. 35-43.
doi:10.1016/S0969-8051(96)00157-6
|
[10]
|
A. H. Al Rayyes and Y. Ailouti, “Routine Simultaneous Production of No-Carrier Added High Purity 64Cu and 67Ga,” Nukleonika, Vol. 56, No. 4, 2011, pp. 259-262.
|
[11]
|
S. V. Smith, D. J. Waters and N. D. Bartolo, “Separation of 64Cu from 67Ga Waste Products Using Anion Exchange and Low Acid Aqueous/Organic Mixtures,” Radiochimica Acta, Vol. 75, No. 2, 1996, pp. 65-68.
|